Telemedical vs. Conventional Prehospital Care in Acute Coronary Syndromes

Acute Coronary Syndrome Clinical Trial

Official title:

Quality Outcomes in Acute Coronary Syndromes Between Telemedically Supported Paramedics and Conventional On-scene Physician Care

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03132935
• Other study ID #: TEMS-ACS
• Status: Completed
• Phase: N/A
• First received: April 24, 2017
• Last updated: April 24, 2017
• Start date: January 1, 2014
• Est. completion date: July 31, 2015

Study information

• Verified date: April 2017
• Source: RWTH Aachen University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Telemedically supported paramedic care of acute coronary syndromes was compared to a historical control period of solely conventional on-scene physician care. Quality outcomes based on current guidelines were researched als well as time requirements in both groups.

Description:

Telemedically supported paramedic care of acute coronary syndromes was compared to a historical control period of solely conventional on-scene physician care. Quality outcomes based on current guidelines were researched als well as time requirements in both groups. All data was collected prospectively for quality management purposes and analyzed retrospectively after ethical approval by the local ethics committee.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 221
• Est. completion date: July 31, 2015
• Est. primary completion date: July 31, 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria: symptoms of acute coronary syndrome -

Exclusion Criteria: secondary transfers from hospital to hospital, traumatic chest pain

Related Conditions & MeSH terms

• Acute Coronary Syndrome
• Syndrome

Intervention

Procedure:
• Telemedical support
Telemedical support by a physician in a telemedicine centre

Locations

Country	Name	City	State
Germany	University Hospital Aachen	Aachen

Sponsors (1)

Lead Sponsor	Collaborator
RWTH Aachen University

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Adverse events	respiratory / circulatory insufficiency, allergic reaction, cardiac arrest	prehospital phase (0.5-2 hours)
Secondary	Correct use of Aspirin	Correct use of Aspirin based on current guidelines	prehospital phase (0.5-2 hours)
Secondary	Correct use of unfractionated Heparin (UFH)	Correct use of UFH based on current guidelines	prehospital phase (0.5-2 hours)
Secondary	Correct use of Morphine	Correct use of Morphine based on current guidelines	prehospital phase (0.5-2 hours)
Secondary	Use of 12-lead-ECG	Use of 12-lead-ECG after first medical contact	prehospital phase (0.5-2 hours)
Secondary	Correct transport destination	hospital with cath lab in ST-segment elevation myocardial infarction or high-risk Non-STEMI-ACS	prehospital phase (0.5-2 hours)
Secondary	Correct use of oxygen	Correct use of Morphine based on current guidelines	prehospital phase (0.5-2 hours)
Secondary	Correct use of Glyceroltrinitrate	Correct use of Glyceroltrinitrate based on current guidelines	prehospital phase (0.5-2 hours)